Drug Courts pp 95-111 | Cite as

Drugs and Alcohol in Pregnancy and the Affected Children

  • Ira J. Chasnoff


Over the past three decades, the use of alcohol and illicit drugs during pregnancy has become a major public health concern. A number of studies have found poor pregnancy outcomes among women who used alcohol or illegal drugs during pregnancy (1, 2, 3, 4, 5), and effects on their newborns also have been documented (6, 7, 8, 9). Recent publications have begun to track the long-term impact of prenatal alcohol or illicit drug exposure on the development and behavior of the exposed child (10, 11, 12, 13, 14, 15, 16).


Illicit Drug Prenatal Exposure Alcohol Exposure Fetal Alcohol Spectrum Disorder Fetal Alcohol Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Chasnoff IJ, Burns WJ, Schnoll SH, Burns KA. Cocaine use in pregnancy. N Engl J Med 1985;313:666–669.PubMedGoogle Scholar
  2. 2.
    Chasnoff IJ, Griffith DR, MacGregor S, Dirkes K, Burns KA. Temporal patterns of cocaine use in pregnancy. JAMA 1989;161:1741–1744.CrossRefGoogle Scholar
  3. 3.
    MacGregor SN, Keith LG. Cocaine use during pregnancy, adverse perinatal outcome. Am J Obstet Gynecol 1987;157:686–690.PubMedGoogle Scholar
  4. 4.
    Shiono PH, Klebanoff MA. The impact of cocaine and marijuana use on low birth weight and preterm birth: a multicenter study. Am J Obstet Gynecol 1995;172:19–27.PubMedCrossRefGoogle Scholar
  5. 5.
    Armstrong MA, Osejo VG, Lieberman L, Carpenter, DM, Pantoja PM, Escobar GJ. Perinatal substance abuse intervention in obstetric clinics decreases adverse neonatal outcomes. J Perinatol 2003;23:3–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Eisen LN, Field TM, Bandstra ES, Roberts JP, Morrow C, Larson SK, Steele BM. Perinatal cocaine effects on neonatal stress behavior and performance on the Brazelton Scale. Pediatrics 1995;88:477–480.Google Scholar
  7. 7.
    Finnegan LP, Connaughton JF, Kron RE, Samuels SJ, Batra KK. Neonatal abstinence syndrome: assessment and management. In Harbison RD, ed. Perinatal Addiction. New York: Spectrum Publications; 1975:141–158.Google Scholar
  8. 8.
    Frank DA, Bauchner H, Parker S, Huber AM, Kyei-Aboagye K, Cabral H, Zuckerman B. Neonatal body proportionality and body composition after inutero exposure to cocaine and marijuana. J Pediatr 1990;117:622–626.PubMedCrossRefGoogle Scholar
  9. 9.
    Lester BM, Corwin MJ, Sepkoski C, Seifer R, Peucher M, McLaughlin S, Golum HL. Neurobehavioral syndromes in cocaine-exposed newborn infants. Child Dev 1991;62:694–705.PubMedCrossRefGoogle Scholar
  10. 10.
    Azuma SD, Chasnoff IJ. Outcome of children prenatally exposed to cocaine and other drugs: a path analysis of three-year data. Pediatrics 1993;92:396–402.PubMedGoogle Scholar
  11. 11.
    Fried PA, Watkinson B. 36-and 48-month neurobehavioral follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol. Dev Behav Pediatr 1990;11(2):49–58.CrossRefGoogle Scholar
  12. 12.
    Hurt H, Brodsky NL, Betancourt L, Braitman LE, Malmud E, Giannetta J. Cocaine-exposed children: follow-up through 30 months. J Subst Abuse 1995;7(3):267–280.CrossRefGoogle Scholar
  13. 13.
    Mayes LC, Bornstein MH, Chawarska K, Granger RH. Information processing and developmental assessments in 3-month-old infants exposed prenatally to cocaine. Pediatrics 1995;95:539–545.PubMedGoogle Scholar
  14. 14.
    Streissguth AP, Sampson P, Barr H. Neurobehavioral dose-response effects of prenatal alcohol exposure in humans from infancy to adulthood. Ann NY Acad Sci 1989;562:145–158.PubMedCrossRefGoogle Scholar
  15. 15.
    Wekselman K, Spiering K, Hetteberg C, Kenner C, Flandermeyer A. Fetal alcohol syndrome from infancy through childhood: a review of the literature. J Pediatr Nurs 1995;15:296–303.CrossRefGoogle Scholar
  16. 16.
    Sood B, Delaney-Black V, Covington C. Prenatal alcohol exposure and childhood behavior at age 6 to 7 years: I. Dose-response effect. Pediatrics 2001;electronic 1–9, 2001.Google Scholar
  17. 17.
    Tatara T. U.S. Child Substitute Care Flow Data for FY 1993 and Trends in the State Child Care Substitute Populations. Washington DC: American Public Welfare Association; 1995.Google Scholar
  18. 18.
    Kilborn PT. Priority on safety is keeping more children in foster care. New York Times. April 29, 1997.Google Scholar
  19. 19.
    Rayburn WF, Bogenschutz MP. Pharmacotherapy for pregnant women with addictions. Am J Obstet Gynecol 2004;191:1885–1897.PubMedCrossRefGoogle Scholar
  20. 20.
    Sood B, Delaney-Black V, Covington C. Prenatal alcohol exposure and childhood behavior at age 6 to 7 years: I. Dose-response effect. Pediatrics 2001;e34,1–9.Google Scholar
  21. 21.
    Maliza B. Most Pregnant Women Don’t Disclose Drug Use. New Orleans: Society for Maternal-Fetal Medicine; 2002.Google Scholar
  22. 22.
    Chasnoff IJ, Landress HJ, Barrett ME. The prevalence of drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. N Engl J Med 1990;1202–1206.Google Scholar
  23. 23.
    Chasnoff IJ, McGourty RF, Bailey GW, Hutchins E, Lightfoot SO, Pawson LL, Fahey C, May B, Brodie P, McCulley L, Campbell J. The 4Ps Plus© Screen for Substance Use in Pregnancy: clinical application and outcomes. J Perinatol 2005;25:368–374.PubMedCrossRefGoogle Scholar
  24. 24.
    Larrson G. Prevention of fetal alcohol effects: an antenatal program for early detection of pregnancies at risk. Acta Obstet Gynecol. Scand 1983;62:171–178.CrossRefGoogle Scholar
  25. 25.
    Chasnoff IJ, Griffith DR, MacGregor S, Dirkes K, Burns KA. Temporal patterns of cocaine use in pregnancy: perinatal outcome. JAMA 1989;261:1741–1744.PubMedCrossRefGoogle Scholar
  26. 26.
    U.S. Preventive Services Task Force Ratings: Strength of Recommendations and Quality of Evidence. Guide to Clinical Preventive Services, 3rd ed. Periodic Updates, 2000–2003. Rockville, MD: Agency for Healthcare Research and Quality; 2003.Google Scholar
  27. 27.
    Stratton K, Howe C, Battaglia F. Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment. Washington, DC: National Academy Press, Institute of Medicine; 1996.Google Scholar
  28. 28.
    National Institute on Alcohol Abuse and Alcoholism and Office of Research on Minority Health, National Institutes of Health. Rockville, MD: U.S. Department of Health and Human Services; 2000.Google Scholar
  29. 29.
    Bertrand J, Floyd RL, Weber MK, O’Connor M, Riley P, Johnson KA, Cohen DE, National Task Force on FAS/FAE. Fetal Alcohol Syndrome: Guidelines for Referral and Diagnosis. Atlanta, GA: Centers for Disease Control and Prevention; 2004.Google Scholar
  30. 30.
    Chasnoff IJ. The Nature of Nurture: Biology, Environment, and the Drug-Exposed Child. Chicago: NTI Publishing; 2001.Google Scholar
  31. 31.
    Riley EP, Mattson SS, Sowell ER, Jernigan TL, Sobel DF, Jones KL. Abnormalities of the corpus callosum in children prenatally exposed to alcohol. Alcohol Clin Exp Res 1995;19:1198–1202.PubMedCrossRefGoogle Scholar
  32. 32.
    Mattson S, Riley EP, Sowell ER, Jernigan TL, Sobel DF, Jones KL. A decrease in the size of the basal ganglia in children with fetal alcohol syndrome. Alcohol Clin Exp Res 1996;20:1088–1093.PubMedCrossRefGoogle Scholar
  33. 33.
    Swayze VW, Johnson VP, Hanson JW, Sato J, Giedd Y, Mosnik JN, Andreasen NC. Magnetic resonance imaging of brain anomalies in fetal alcohol syndrome. Pediatrics 1997;99:232–241.PubMedCrossRefGoogle Scholar
  34. 34.
    Mattson SN, Riley EP, Gramling L, Delis DC, Jones KL. Neuropsychological comparison of alcohol-exposed children with or without physical features of fetal alcohol syndrome. Neuropsychology 1998;12:46–153.CrossRefGoogle Scholar
  35. 35.
    Clark CM, Li DC, Conry J, Loock R. Structural and functional brain integrity of fetal alcohol syndrome in nonretarded cases. Pediatrics 2000;105:1096–2011.PubMedCrossRefGoogle Scholar
  36. 36.
    Bertrand J, Floyd RL, Weber MK, O’Connor M, Riley P, Johnson KA, Cohen DE, National Task Force on FAS/FAE. Fetal Alcohol Syndrome: Guidelines for Referral and Diagnosis. Atlanta, GA: Centers for Disease Control and Prevention; 2004.Google Scholar
  37. 37.
    Fried PA, Smith AM. A literature review of the consequences of prenatal marihuana exposure: an emerging theme of a deficiency in aspects of executive function. Neurotoxicol Teratol 2001;23:1–11.PubMedCrossRefGoogle Scholar
  38. 38.
    Chasnoff IJ, Anson A, Hatcher R, Stenson H, Iaukea K, Randolph L. Prenatal exposure to cocaine and other drugs: outcome at four to six years. In Harvey JA, Kosofsky BE, eds. Cocaine Effects on the Developing Brain. New York: New York Academy of Sciences, 1998;314–328.Google Scholar
  39. 39.
    Chasnoff IJ, Bussey M, Savich R, Stack CA. Perinatal cerebral infarction and maternal cocaine use. J Pediatr 1986;108:456–459.PubMedCrossRefGoogle Scholar
  40. 40.
    Chasnoff IJ, Hatcher R, Burns WJ. Early growth patterns of methadone-addicted infants. Am J Dis Child 1980;134:1049–1051.PubMedGoogle Scholar
  41. 41.
    Chasnoff IJ, Burns WJ and Hatcher R. Polydrug-and methadone-addicted newborns: a continuum of impairment? Pediatrics 1982;70:210–212.PubMedGoogle Scholar
  42. 42.
    Hurt H, Giannetta J, Brodsky NL, et al. Are there neurologic correlates of in utero cocaine exposure at age six years? J Pediatr 2001;138:911–913.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Ira J. Chasnoff
    • 1
  1. 1.University of Illinois Hospital, Children’s Research TriangleChicagoUSA

Personalised recommendations